Tag Archives: FDA

AmerisourceBergen selected by Deciphera to support QINLOCK (ripretinib)

AmerisourceBergen’s commercialization support services offer an integrated approach to drug launches

Lundbeck’s Vyepti Distributed by Only Two Specialty Pharmacies

Lundbeck has named AllianceRx and Orsini as the only two specialty pharmacies to distribute Vyepti

Programs Covering the Cost of Gene Therapies Increase

Cell and gene therapies are revolutionizing the field of medicine by offering life-changing benefits to people with rare diseases and cancers

Market Access Programs for Gene Therapies Increasing

Payers are planning for an increasing number of gene therapies being approved by developing new coverage programs

Jelmyto Poised for Successful Commercial Launch

UroGen has been preparing for the commercialization of Jelmyto by increasing customer awareness and discussing the high unmet need in low-grade UTUC

Heartline Study Increases Apple Research’s Clinical Trial Growth

New digital technologies offer a different approach to capturing, analyzing and predicting patient behavior.

ProofPilot Collaboration Increasing Access to Timely Research

The influx of new digital technologies has offered the clinical trial industry a systemized approach to collect and analyze patient behavior

etectRx Gaining Upper Hand in Bioingestible Sensors Market

etectRx and Proteus Digital Health are the only two companies offering Bioingestible sensors